FWP
AZN icon

FAS Wealth Partners’s AstraZeneca AZN Stock Holding History

FAS Wealth Partners’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$264K Hold
1,390
– – 0.01% 317
2026
Q1 		$274K Sell
1,390
-77
-5% -$14.8K 0.02% 301
2025
Q4 		$270K Buy
1,467
+100
+7% +$17.5K 0.02% 299
2025
Q3 		$210K Buy
+1,367
New +$207K 0.01% 308
2024
Q4 		– Sell
-1,332
Closed -$208K – 431
2024
Q3 		$208K Buy
1,332
+7
+0.5% +$1.13K 0.02% 296
2024
Q2 		$207K Buy
+1,325
New +$199K 0.02% 286
2023
Q2 		– Sell
-3,209
Closed -$445K – 413
2023
Q1 		$445K Sell
3,209
-24
-0.7% -$3.23K 0.05% 204
2022
Q4 		$438K Buy
3,233
+38
+1% +$4.76K 0.05% 208
2022
Q3 		$350K Buy
3,195
+8
+0.3% +$1.01K 0.04% 212
2022
Q2 		$421K Hold
3,187
– – 0.04% 198
2022
Q1 		$423K Buy
3,187
+14
+0.4% +$1.68K 0.04% 202
2021
Q4 		$370K Buy
3,173
+227
+8% +$26.7K 0.03% 226
2021
Q3 		$354K Buy
2,946
+215
+8% +$25K 0.03% 215
2021
Q2 		$327K Hold
2,731
– – 0.03% 224
2021
Q1 		$272K Buy
2,731
+6
+0.2% +$603 0.03% 227
2020
Q4 		$272K Buy
2,725
+190
+7% +$20.1K 0.03% 219
2020
Q3 		$278K Buy
2,535
+2
+0.1% +$222 0.04% 206
2020
Q2 		$268K Hold
2,533
– – 0.04% 201
2020
Q1 		$226K Buy
2,533
+7
+0.3% +$659 0.04% 197
2019
Q4 		$252K Hold
2,526
– – 0.04% 177
2019
Q3 		$225K Buy
+2,526
New +$219K 0.04% 184

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

FAS Wealth Partners's AZN Position: Q2 2026 in Review

FAS Wealth Partners held its AstraZeneca (AZN) position steady in Q2 2026 at 1,390 shares worth $264K. The position accounts for 0.01% of the portfolio, ranked #317.

FAS Wealth Partners first reported a position in AZN in Q3 2019 and has held it in 21 quarters since. The position peaked at $445K in Q1 2023. 1,504 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • FAS Wealth Partners held 1,390 shares of AstraZeneca worth $264K as of Q2 2026.
  • FAS Wealth Partners left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up 0.01% of FAS Wealth Partners's portfolio in Q2 2026, its #317 holding.
  • FAS Wealth Partners first reported a position in AstraZeneca in Q3 2019 and has held it in 21 quarters since.
  • FAS Wealth Partners's AstraZeneca position peaked at $445K in Q1 2023.
  • 1,504 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on FAS Wealth Partners's 13F filing for Q2 2026, filed 29 Jul 2026.